CGDXF News Alert Candente Gold (CGDXF) 0.0220 09/26/2014 08:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Candente Gold (CGDXF) 0.0220 $CGDXF

Candente Gold Provides Voting Results for the Election of Directors and Confirms Filing of 43-101 Report on Inferred Resource Estimate
Marketwire - Fri Aug 29, 3:01AM CDT
Candente Gold Corp. (TSX: CDG) ("Candente Gold" and/or the "Company" ) is pleased to provide the voting results for the election of directors at its annual general meeting of shareholders held on August 21, 2014.

Candente Gold Announces El Oro Tailings Inferred Resource Contains 119,900 oz Gold and 3M oz Silver
Marketwire - Thu Jul 10, 3:00AM CDT
Candente Gold Corp. (TSX: CDG)(LMA: CDG) ("Candente Gold" or "the Company" is pleased to report that an Inferred Mineral Resource Estimate has been completed on the Mexico Mines tailings deposit under option from the Municipality of El Oro de Hidalgo in Mexico.

Candente Gold Corp.: High Gold and Silver Grades Confirmed for the El Oro Mine Tailings
Marketwire - Thu Jun 26, 3:06AM CDT
Candente Gold Corp. (TSX: CDG)(LMA: CDG) ("Candente Gold" or "the Company" is pleased to report that an auger and channel sampling program has been completed on the Mexico Mines tailings deposit under option from the municipality of El Oro in Mexico.

Candente Gold Michael J. Casselman
Marketwire - Thu Jan 30, 3:01AM CST
Candente Gold Corp. (TSX: CDG)(LMA: CDG) ("Candente Gold" or the "Company" with great sadness we regretfully announce the passing of director Michael Casselman.

Candente Gold closes Non-Brokered Private Placement
Marketwire - Thu Jan 23, 3:00AM CST
Candente Gold Corp. (TSX: CDG)(BVL: CDG) ("Candente Gold" or the "Company" is pleased to announce it has completed its previously announced non-brokered private placement (see the company's new releases dated December 17 and 24, 2013), closing on a second tranche of $476,025, for a total of $746,025. Candente Gold has issued 14,920,500 common shares at a price of $0.05 per common share related to both tranches of the financing.

Candente Gold Corp. Acquires the Rights to El Oro Mexico Mine Tailings
Marketwire - Thu Jun 13, 3:00AM CDT
Candente Gold Corp. (TSX: CDG)(LMA: CDG) ("Candente Gold" is pleased to report that its Mexican subsidiary company, Minera CCM El Oro Jales S.A. de CV, has signed an agreement for the access and processing rights to historic gold and silver tailings deposits in the El Oro District of Mexico State, central Mexico, where mining grades were in the range of 19 to 80 grams per tonne ("g/t" gold and 240 to 800 g/t silver.

Candente Gold Appoints Dr. Kenneth G. Thomas to Board of Directors
Marketwire - Wed Mar 13, 3:01AM CDT
Candente Gold Corp. (TSX: CDG)(LMA: CDG) ("Candente Gold" is pleased to report the appointment of Dr. Kenneth ("Ken" G. Thomas to its Board of Directors.

Candente Gold Updates on El Oro Exploration Progress
Marketwire - Thu Feb 28, 3:01AM CST
Candente Gold Corp. (TSX: CDG)(LMA: CDG) ("Candente Gold" is pleased to provide an update on the continuing definition of gold-silver mineralization at its El Oro Project in central Mexico. Following a recent Director's visit to the property, Candente Gold is of the opinion that the El Oro project has met a major milestone in the ongoing compilation of the historical work by identifying previously unrecognized and untested controls for potential higher grade mineralization.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Infosys Pushes AI Growth with Strong Deal Wins

Updated Category News Views 17

Riding the AI Wave Who knew Infosys was a lightning rod for AI momentum, eh? With a 29% quarterly surge in AI revenue, the firm's really putting AI strategy at center stage. Considering today's finicky markets, that's not just peanuts. CEO Salil Parekh's swagger is backed by real numbers, seeing AI revenue inch to 10.5% of total haul. This ain't just talk—Infosys is...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 10

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 48

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 37

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading
SLM Faces Legal Scrutiny as Losses Mount Amid Pause

Updated Category News Views 36

SLM's Latest Troubles: Legal and Financial Impact Ah, student loans—not just a headache for borrowers but now for lenders too. SLM Corporation, that name we know all too well in the student debt circus, has hit a snag. They've paused most of their third-party recovery activities. Let's dig in: net charge-offs for SLM in the third quarter shot up to a hefty $90.4...

Continue Reading
Pathalys' Phase 3 Data Shows Promise for CKD Drug

Updated Category News Views 30

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

Continue Reading
Stephen A. Smith Calls for Corporate Support of HBCUs

Updated Category News Views 4

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

Continue Reading
Violet PR's Big Wins Hint at Industry Strategies

Updated Category News Views 15

A Shining Night in Morristown Picture Violet PR's team on top of the world, right there in Morristown, getting the accolades every agency dreams of—five awards from PRSA-NJ. It's not just an ego trip, either. This is about setting a high bar in the world of strategic communications, and they're flaunting their ability to drive growth and innovation in the economic...

Continue Reading
BOB Raises $5.5M for AI Banking Platform Revolution

Updated Category News Views 24

Cracking the Code of Small Business Finance BOB, a Miami hotshot aiming to be more than just another fintech flash in the pan, has wrangled a sweet $5.5 million in seed capital. They're shaking hands with big names like Peter Thiel and the mastermind behind Plaid, Zak Perret, through Mischief Ventures. The plan? To build an AI-powered finance savior for small businesses...

Continue Reading
GeeLark's Tech Leap: Expanding Cloud Phone Functions

Updated Category News Views 3

GeeLark's New Frontier GeeLark is kicking up some dust in the tech space by tooling up its cloud phone workflows with an arsenal of new supports: API, CLI, and MCP. This isn't just some minor patch, folks. It's a bold move, and for those in the quicksand of digital operations, a game-changer. You know how much of a drag it is repeating the same setup steps over and over?...

Continue Reading

Top 5 Most Recently Viewed Articles

CoinW Showcases Its Innovations at Taipei Blockchain Week 2024

Updated Category News Views 261

CoinW's Impactful Presence at Taipei Blockchain Week 2024 At the forefront of innovation and security, CoinW, a globally recognized cryptocurrency exchange, recently showcased its vision for the future during Taipei Blockchain Week 2024 as a Gold Sponsor. The event, celebrated for fostering discussions on blockchain advancements, featured the launch of PropW, CoinW's...

Continue Reading
Bank of Åland Plc Seeks Trading Admission of New Covered Bonds

Updated Category News Views 170

Application for Trading Admission of Covered Bonds Bank of Åland Plc, also recognized as Ålandsbanken Abp, is taking an important step by applying for the admission of a new security to trading on Nasdaq Helsinki. This involves their recent issuance of covered bonds, which are highly regarded in the financial market. Details of the Covered Bonds Issue The primary...

Continue Reading
Simpson Manufacturing's Q3 Earnings Report Shows Challenges Ahead

Updated Category News Views 54

Simpson Manufacturing's Third Quarter Performance Simpson Manufacturing Co., Inc. (NYSE: SSD) recently announced its third-quarter earnings, and the results did not meet the expectations of analysts. This disappointing performance resulted in a 5% decline in shares during after-hours trading. The company's focus on producing wood construction products highlights the...

Continue Reading
Alvotech Faces Challenges in Biologics License Approval Process

Updated Category News Views 349

Overview of Biologics License Application Status Alvotech, a prominent biotech firm specializing in biosimilars, has recently updated the market regarding its application status for AVT05, a potential competitor to Simponi (golimumab). The company has received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) highlighting certain...

Continue Reading
Replimune Group Faces Class Action Lawsuit Amid FDA Setback

Updated Category News Views 127

Replimune Group Faces Class Action Lawsuit Amid FDA Setback Pomerantz LLP has brought attention to a class action lawsuit involving Replimune Group, Inc. (NASDAQ: REPL). This legal action is relevant for investors who have experienced losses on their investments in the company. It's crucial for affected investors to be proactive and consider their options as they navigate...

Continue Reading